In this episode, he and Niklas explore how genome sequencing, DNA synthesis, and CRISPR are turning life into an engineering platform. From coding proteins and viruses to writing entire genomes, Andrew explains how biotech is moving from reading DNA to actively programming it.
They discuss N-of-1 personalized therapies, biosecurity in an age of cheap DNA synthesis, and why open science could accelerate biotech innovation. The conversation also touches on cloning, embryo editing, and the long-term future of human enhancement.
Topics include:
· DNA as digital code
· Genome writing and synthetic cells
· CRISPR and programmable biology
· Personalized genetic medicine
· Biosecurity and engineered viruses
· Open biotech vs. proprietary models
· Cloning and human genome design
A conversation for builders, founders, and technologists thinking about biology as the next software layer.
